Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT03737643
PHASE3

Durvalumab Treatment in Combination With Chemotherapy and Bevacizumab, Followed by Maintenance Durvalumab, Bevacizumab and Olaparib Treatment in Advanced Ovarian Cancer Patients

Sponsor: AstraZeneca

View on ClinicalTrials.gov

Summary

This is a Phase III randomised, double-blind, multi-centre study to evaluate the efficacy and safety of durvalumab in combination with standard of care platinum based chemotherapy and bevacizumab followed by maintenance durvalumab and bevacizumab or durvalumab, bevacizumab and olaparib in patients with newly diagnosed advanced ovarian cancer.

Official title: A Phase III Randomised, Double-Blind, Placebo-Controlled, Multicentre Study of Durvalumab in Combination With Chemotherapy and Bevacizumab, Followed by Maintenance Durvalumab, Bevacizumab and Olaparib in Newly Diagnosed Advanced Ovarian Cancer Patients (DUO-O).

Key Details

Gender

FEMALE

Age Range

18 Years - 130 Years

Study Type

INTERVENTIONAL

Enrollment

1407

Start Date

2019-01-04

Completion Date

2026-12-23

Last Updated

2026-07-07

Healthy Volunteers

No

Interventions

DRUG

Bevacizumab

Bevacizumab by intravenous infusion. In tBRCAm cohort bevacizumab is optional according to local practice.

DRUG

Durvalumab

Durvalumab by intravenous infusion

DRUG

Olaparib

Olaparib tablets

DRUG

Placebo olaparib

Placebo tablets to match olaparib

DRUG

Durvalumab placebo

Matching placebo for intravenous infusion

DRUG

Carboplatin+Paclitaxel

Standard of care chemotherapy

Locations (214)

Research Site

Foothill Ranch, California, United States

Research Site

Los Angeles, California, United States

Research Site

Orange, California, United States

Research Site

San Francisco, California, United States

Research Site

Tampa, Florida, United States

Research Site

Augusta, Georgia, United States

Research Site

Hinsdale, Illinois, United States

Research Site

Indianapolis, Indiana, United States

Research Site

Towson, Maryland, United States

Research Site

Detroit, Michigan, United States

Research Site

Springfield, Missouri, United States

Research Site

Middletown, New Jersey, United States

Research Site

Montvale, New Jersey, United States

Research Site

Albany, New York, United States

Research Site

New York, New York, United States

Research Site

Uniondale, New York, United States

Research Site

Durham, North Carolina, United States

Research Site

Cleveland, Ohio, United States

Research Site

Dayton, Ohio, United States

Research Site

Hilliard, Ohio, United States

Research Site

Tulsa, Oklahoma, United States

Research Site

Lancaster, Pennsylvania, United States

Research Site

Philadelphia, Pennsylvania, United States

Research Site

Philadelphia, Pennsylvania, United States

Research Site

Pittsburgh, Pennsylvania, United States

Research Site

Salt Lake City, Utah, United States

Research Site

Graz, Austria

Research Site

Innsbruck, Austria

Research Site

Linz, Austria

Research Site

Vienna, Austria

Research Site

Aalst, Belgium

Research Site

Leuven, Belgium

Research Site

Namur, Belgium

Research Site

Ostend, Belgium

Research Site

Sint-Niklaas, Belgium

Research Site

Barretos, Brazil

Research Site

Florianópolis, Brazil

Research Site

Fortaleza, Brazil

Research Site

Londrina, Brazil

Research Site

Porto Alegre, Brazil

Research Site

Porto Alegre, Brazil

Research Site

Rio de Janeiro, Brazil

Research Site

São Paulo, Brazil

Research Site

São Paulo, Brazil

Research Site

Burgas, Bulgaria

Research Site

Plovdiv, Bulgaria

Research Site

Sofia, Bulgaria

Research Site

Varna, Bulgaria

Research Site

Calgary, Alberta, Canada

Research Site

Barrie, Ontario, Canada

Research Site

Greater Sudbury, Ontario, Canada

Research Site

Toronto, Ontario, Canada

Research Site

Montreal, Quebec, Canada

Research Site

Montreal, Quebec, Canada

Research Site

Montreal, Quebec, Canada

Research Site

Québec, Quebec, Canada

Research Site

Rimouski, Quebec, Canada

Research Site

Beijing, China

Research Site

Beijing, China

Research Site

Bengbu, China

Research Site

Changchun, China

Research Site

Changsha, China

Research Site

Changsha, China

Research Site

Chengdu, China

Research Site

Chongqing, China

Research Site

Dalian, China

Research Site

Guangzhou, China

Research Site

Guangzhou, China

Research Site

Hangzhou, China

Research Site

Hangzhou, China

Research Site

Harbin, China

Research Site

Hefei, China

Research Site

Jinhua, China

Research Site

Kunming, China

Research Site

Lanzhou, China

Research Site

Luzhou, China

Research Site

Nanchong, China

Research Site

Nanjing, China

Research Site

Nanning, China

Research Site

Nantong, China

Research Site

Shanghai, China

Research Site

Shanghai, China

Research Site

Wuhan, China

Research Site

Wuhan, China

Research Site

Xi'an, China

Research Site

Zhengzhou, China

Research Site

Zhengzhou, China

Research Site

Zhuhai, China

Research Site

Aalborg, Denmark

Research Site

Aarhus N, Denmark

Research Site

Odense, Denmark

Research Site

Roskilde, Denmark

Research Site

Vejle, Denmark

Research Site

Kuopio, Finland

Research Site

Oulu, Finland

Research Site

Turku, Finland

Research Site

Besançon, France

Research Site

Bordeaux, France

Research Site

Limoges, France

Research Site

Lyon, France

And 114 more locations on ClinicalTrials.gov